BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19541124)

  • 1. [FDG PET/CT and childhood Hodgkin lymphoma].
    Montravers F; Kerrou K; Huchet V; Pascal O; Talbot JN
    Arch Pediatr; 2009 Jun; 16(6):669-71. PubMed ID: 19541124
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT.
    Sheehy N; Israel DA
    Clin Nucl Med; 2007 Oct; 32(10):820-1. PubMed ID: 17885370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG-PET/CT findings in a patient with tuberculosis Hodgkin's disease and lupus vulgaris.
    Kaya E; Halac M; Sönmezoglu K; Sager S; Uslu I
    Hell J Nucl Med; 2009; 12(3):285-6. PubMed ID: 19936348
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidental inflammatory findings in nerves and in patients with neoplastic diseases evaluated by 18F-FDG-PET/CT.
    Bertagna F; Giubbini R; Biasiotto G; Rosenbaum J; Alavi A
    Hell J Nucl Med; 2009; 12(3):279-80. PubMed ID: 19936345
    [No Abstract]   [Full Text] [Related]  

  • 5. False positivity of FDG-PET/CT in a child with Hodgkin disease.
    Beker DB; Berrak SG; Canpolat C; Tugtepe H; Ones T; Tecimer T
    Pediatr Blood Cancer; 2008 Apr; 50(4):881-3. PubMed ID: 17417791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
    Coha B; Radmilović K; Gardasanić J; Daković M; Stefanić M; Latić A; Mitrecić D
    Acta Clin Croat; 2009 Mar; 48(1):35-9. PubMed ID: 19623870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT for therapy response assessment in lymphoma.
    Hutchings M; Barrington SF
    J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
    Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
    Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic sequelae of herpes simplex encephalitis demonstrated on interictal F-18 FDG PET/CT.
    Wong KK; Tolia B; Bohnen N
    Clin Nucl Med; 2008 Jun; 33(6):443-4. PubMed ID: 18496462
    [No Abstract]   [Full Text] [Related]  

  • 10. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
    Weijs LE; Arsos G; Baarslag HJ; Wittebol S; de Klerk JM
    Eur Heart J; 2007 Nov; 28(22):2698. PubMed ID: 17567624
    [No Abstract]   [Full Text] [Related]  

  • 11. Pitfalls of positron emission tomography for assessing relapse in Hodgkin's disease: a case report.
    Pitini V; Navarra G; Cavallari V; Arrigo C; Naro C; Altavilla G
    Haematologica; 2006 Aug; 91(8 Suppl):ECR38. PubMed ID: 16923522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of fluorine-18-FDG PET-CT scans in initial management and follow-up of patients with cutaneous melanoma].
    Sarandi F; Hindié E; Kerob D; Basset-Seguin N; Lebbé C; Toubert ME; Filmont JE; Groheux D; Teyton P; Moretti JL
    Ann Dermatol Venereol; 2008 Oct; 135(10):691-9. PubMed ID: 18929924
    [No Abstract]   [Full Text] [Related]  

  • 13. Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by ¹⁸F-FDG PET/CT.
    Mapelli P; Vanoli EG; Picchio M; Gianolli L
    Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):125. PubMed ID: 23246137
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of F-18 FDG-PET/CT in diagnosis of chronic empyema-associated malignancy.
    Oh JK; Ahn MI; Kim CH; Cho KD; Cho DG; Kang CU; Yoo J
    Clin Radiol; 2008 Oct; 63(10):1177-80. PubMed ID: 18774367
    [No Abstract]   [Full Text] [Related]  

  • 15. FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
    Karam M; Ata A; Irish K; Feustel PJ; Mottaghy FM; Stroobants SG; Verhoef GE; Chundru S; Douglas-Nikitin V; Oliver Wong CY; Brepoels LM
    Nucl Med Commun; 2009 Oct; 30(10):770-8. PubMed ID: 19657307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung cancer detected by fluorodeoxyglucose-positron emission tomography/computed tomography in the course of Mycobacterium avium infection; report of a case].
    Adachi K; Kaneda M; Sakai T; Fujimoto H; Ibata H; Omoto Y; Watanabe F
    Kyobu Geka; 2009 Oct; 62(11):1019-21. PubMed ID: 19827559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PET/CT report: the most important part of the study.
    Graham MM
    J Nucl Med; 2010 Jan; 51(1):5-6. PubMed ID: 20008996
    [No Abstract]   [Full Text] [Related]  

  • 19. PET/CT: More than the sum of two established imaging modalities?
    Kletter K
    Eur J Radiol; 2010 Mar; 73(3):449-51. PubMed ID: 20097026
    [No Abstract]   [Full Text] [Related]  

  • 20. [PET/CT: The next big technical advance in medicine in Iceland].
    Hannesson P
    Laeknabladid; 2008 Feb; 94(2):101. PubMed ID: 18310773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.